blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0430200

EP0430200 - Drug for s.c. or i.m. application containing polypeptides [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.04.1995
Database last updated on 11.09.2024
Most recent event   Tooltip08.04.1995No opposition filed within time limitpublished on 31.05.1995 [1995/22]
Applicant(s)For all designated states
BEHRINGWERKE Aktiengesellschaft
Postfach 1140
35001 Marburg / DE
[N/P]
Former [1994/40]For all designated states
BEHRINGWERKE Aktiengesellschaft
Postfach 1140
D-35001 Marburg / DE
Former [1991/23]For all designated states
Behringwerke Aktiengesellschaft
Postfach 11 40
D-35001 Marburg / DE
Inventor(s)01 / Paques, Eric-Paul, Dr.
Schmiedeacker 18
W-3550 Marburg / DE
[1991/23]
Representative(s)(deleted)
[1993/37]
Former [1992/23]Fischer, Hans-Jürgen, Dr., et al
Hoechst AG Patent- und Lizenzabteilung Gebäude K 801
D-65926 Frankfurt am Main / DE
Former [1991/23]Klein, Otto, Dr.
Hoechst AG, Werk Gendorf, Patentbüro
D-84504 Burgkirchen / DE
Application number, filing date90122730.628.11.1990
[1991/23]
Priority number, dateDE1989393934629.11.1989         Original published format: DE 3939346
[1991/23]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0430200
Date:05.06.1991
Language:DE
[1991/23]
Type: B1 Patent specification 
No.:EP0430200
Date:08.06.1994
Language:DE
[1994/23]
Search report(s)(Supplementary) European search report - dispatched on:EP25.03.1991
ClassificationIPC:A61K37/54, A61K37/02, A61K47/18, // (A61K37/54, 37:02, 31:195)
[1991/23]
CPC:
A61K9/0019 (EP,US); A61K9/08 (KR); A61K38/1816 (EP,US);
A61K38/36 (EP,US); A61K38/49 (EP,US); A61K38/58 (EP,US);
A61K47/183 (EP,US) (-)
C-Set:
A61K38/1816, A61K2300/00 (EP,US);
A61K38/1816, A61K31/195 (US,EP);
A61K38/36, A61K2300/00 (EP,US);
A61K38/36, A61K31/195 (US,EP);
A61K38/49, A61K2300/00 (EP,US);
A61K38/49, A61K31/195 (US,EP);
A61K38/58, A61K2300/00 (EP,US);
A61K38/58, A61K31/195 (US,EP)
(-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/23]
TitleGerman:Arzneimittel zur subkutanen oder intramuskulären Applikation enthaltend Polypeptide[1991/23]
English:Drug for s.c. or i.m. application containing polypeptides[1991/23]
French:Médicament pour application s.c. ou i.m. contenant des polypeptides[1991/23]
Examination procedure21.12.1990Examination requested  [1991/23]
16.07.1992Despatch of a communication from the examining division (Time limit: M04)
24.11.1992Reply to a communication from the examining division
23.12.1992Despatch of a communication from the examining division (Time limit: M02)
01.03.1993Reply to a communication from the examining division
12.05.1993Despatch of communication of intention to grant (Approval: No)
10.11.1993Despatch of communication of intention to grant (Approval: later approval)
19.11.1993Communication of intention to grant the patent
15.01.1994Fee for grant paid
15.01.1994Fee for publishing/printing paid
Opposition(s)09.03.1995No opposition filed within time limit [1995/22]
Fees paidRenewal fee
16.10.1992Renewal fee patent year 03
18.10.1993Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0156169  (ASAHI CHEMICAL IND [JP]);
 [X]EP0303251  (EISAI CO LTD [JP]);
 [X]US4857320  (WITTWER ARTHUR J [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.